OpRegen® 3-Year Data in Geographic Atrophy Patients Showcased at Foundation Fighting Blindness Retinal Innovation Summit 2026 Lineage Cell Therapeutics (NYSE American and TASE: LCTX), a clinical-stage biotechnology company focused on…
Rejoni Names John Nealon as Chief Executive Officer to Lead Its Women’s Health MedTech Strategy Rejoni Inc., a privately held clinical-stage biotechnology company focused on advancing uterine health through innovative…
Takeda Pharmaceutical Company Reports Positive Topline Results from Pivotal Phase 2/3 Study of TAK-881 in Primary Immunodeficiency Disease Takeda Pharmaceutical Company (TSE:4502/NYSE:TAK) has reported positive topline results from its pivotal…
Assertio Enters into Revised and Restated Merger Agreement with Garda Therapeutics Assertio Holdings has announced a significant update to its pending acquisition by Garda Therapeutics, revealing that the two companies…
New Study Demonstrates Sensome’s Clot-Sensing Guidewire Precisely Identifies Clot Composition in Fully Occluded Brain Vessels for the First Time Sensome, a biotechnology innovator specializing in microsensing technology for real-time intra-operative…
Satellite Bio Secures U.S. Food and Drug Administration Rare Pediatric Disease Designation for SB-101 in Urea Cycle Disorders Satellite Biosciences has announced a significant regulatory milestone, revealing that the U.S.…
Ironwood Presents Survey Data at DDW 2026 Highlighting Urgent Need for Treatments Addressing the Multifaceted Burden of Total Parenteral Nutrition in Short Bowel Syndrome Ironwood Pharmaceuticals, a biotechnology company focused…
Insulet Launches EVOLVE Pivotal Trial to Accelerate Development of a Fully Closed-Loop Insulin Delivery System for Type 2 Diabetes Insulet Corporation, a global pioneer in tubeless insulin pump technology through…
UCB Expands Immunology Pipeline with Planned Acquisition of Candid Therapeutics and Its Novel T-Cell Engager Platform UCB has taken a significant step forward in its strategic expansion within immunology by…
J&J Highlights FDA Approval of STELARA® for Pediatric Crohn’s Disease The U.S. Food and Drug Administration (FDA) has approved STELARA (ustekinumab) for the treatment of pediatric patients aged two years…
Incyte Secures FDA Approval for Jakafi XR™ (ruxolitinib) Extended-Release Tablets Across Multiple Hematologic Indications Incyte has announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib)…
Orthogon Therapeutics Secures Additional $11M to Advance BK Virus Antiviral Drug Program Orthogon Therapeutics has announced the successful close of an additional $11 million in follow-on financing, bringing the company’s…